Byrne Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21K | Hold |
300
| – | – | 0.01% | 326 |
|
|
2025
Q1 | $22.1K | Hold |
300
| – | – | 0.02% | 330 |
|
|
2024
Q4 | $19.7K | Hold |
300
| – | – | 0.01% | 294 |
|
|
2024
Q3 | $23.4K | Hold |
300
| – | – | 0.02% | 277 |
|
|
2024
Q2 | $23.5K | Hold |
300
| – | – | 0.02% | 268 |
|
|
2024
Q1 | $20.3K | Hold |
300
| – | – | 0.01% | 296 |
|
|
2023
Q4 | $20.2K | Hold |
300
| – | – | 0.02% | 289 |
|
|
2023
Q3 | $20K | Hold |
300
| – | – | 0.02% | 267 |
|
|
2023
Q2 | $21K | Sell |
300
-165
| -35% | -$11.6K | 0.01% | 316 |
|
|
2023
Q1 | $32K | Hold |
465
| – | – | 0.02% | 262 |
|
|
2022
Q4 | $31.5K | Buy |
465
+165
| +55% | +$11.2K | 0.02% | 272 |
|
|
2022
Q3 | $16K | Hold |
300
| – | – | 0.01% | 318 |
|
|
2022
Q2 | $20K | Hold |
300
| – | – | 0.01% | 275 |
|
|
2022
Q1 | $20K | Hold |
300
| – | – | 0.01% | 306 |
|
|
2021
Q4 | $17K | Buy |
+300
| New | +$17K | 0.01% | 309 |
|